Search results for: "Novo Nordisk"

(167 records)

Manufacturing
Novo Nordisk invests DKK 8.5bn into new Danish modular production site

Novo Nordisk invests DKK 8.5bn into new Danish modular production site

This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within...
Manufacturing
Novavax sells protein manufacturing facility to Novo Nordisk for $200m

Novavax sells protein manufacturing facility to Novo Nordisk for $200m

Novo Nordisk's purchase of Novavax's Czech recombinant protein manufacturing facility will involve a full transfer of assets — including its workforce and associated support...
Manufacturing
Novo Nordisk acquires license to Ascendis Pharma's TransCon tech for up to $286m

Novo Nordisk acquires license to Ascendis Pharma's TransCon tech for up to $286m

Novo Nordisk will use the technology to develop, manufacture and commercialise therapeutics for metabolic and cardiovascular diseases
Regulatory
Novo Nordisk's haemophilia A/B drug Alhemo gets positive opinion from the EMA

Novo Nordisk's haemophilia A/B drug Alhemo gets positive opinion from the EMA

The subcutaneous, self-administering prophylactic can allow a patient to produce thrombin, a clotting agent, even in the presence of inhibitors
Regulatory
Novo Nordisk's Wegovy gains positive opinion from the EMA for cardiovascular event risk reduction

Novo Nordisk's Wegovy gains positive opinion from the EMA for cardiovascular event risk reduction

The GLP-1 medication has proven effective at reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease
Manufacturing
Novo Nordisk teams up with Bio Farma and Indonesian government to enhance national diabetes drug accessibility

Novo Nordisk teams up with Bio Farma and Indonesian government to enhance national diabetes drug accessibility

The collaboration will aim to enhance the availability of insulin and other diabetes drug products in Indonesia, where diabetes is one of the top three killers annually
Distribution
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride

Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride

The two companies aim to expand the distribution of benzalkonium chloride within Europe
Regulatory
Anti-IL-21 monoclonal antibody licensed by Almirall

Anti-IL-21 monoclonal antibody licensed by Almirall

NN-8828, the IL-21 blocker, is exclusively owned by Almirall and will be used to treat immune inflammatory dermatological diseases
Manufacturing
BioInnovation adds eight early-stage companies to acceleration programme

BioInnovation adds eight early-stage companies to acceleration programme

Lomo, Novozymes and Amalus are all among the eight countries selected by BII to join its acceleration programme for early-stage companies looking to strike out into the...
Ingredients
Therapeutic: olutasidenib for acute myeloid leukaemia

Therapeutic: olutasidenib for acute myeloid leukaemia

Acute myeloid leukaemia (AML) is a blood cancer that progresses rapidly; it’s characterised by the fast build-up of abnormal cells in the bone marrow that adversely affects...
Manufacturing
Data shows insulin icodec meets additional endpoints in adults with type 2 diabetes in phase 3a trials

Data shows insulin icodec meets additional endpoints in adults with type 2 diabetes in phase 3a trials

The results were shared at the 83rd Annual Scientific Sessions of the American Diabetes Association (ADA)
Drug Delivery
Novo invests $40m in proteomics technology company

Novo invests $40m in proteomics technology company

The investment will be used to advance clinical applications of proteomics enabled by Evosep’s standardised liquid chromatography platform
Finance
Novo enters research partnership with Flagship Pioneering

Novo enters research partnership with Flagship Pioneering

Novo Nordisk will provide funding for initiated research programmes and have an exclusive option to license each programme
Research & Development
Novo Nordisk and MIT extend oral delivery tech collaboration

Novo Nordisk and MIT extend oral delivery tech collaboration

Since 2015, the industry-academia venture has explored alternatives to syringe and pen-based delivery of biologics
Finance
Novo companies announce enzyme collaboration for biopharmaceuticals

Novo companies announce enzyme collaboration for biopharmaceuticals

Enzymes used in biopharmaceutical processing make up a small part of the 15bn DKK ($2.3bn) market for specialty enzymes, with yearly expected growth rates in the high-single...
Design & Build
Novo Nordisk plans $117m API manufacturing expansion

Novo Nordisk plans $117m API manufacturing expansion

Danish company’s Kalundborg headquarters that manufactures insulin API will be expanded by 2022

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. Bausch and Lomb hit with FDA Warning Letter for persistent microbial contamination The regulator cited persistent out-of-limit microbial recoveries in ISO 5 areas, deficiencies in aseptic processing and airflow controls and an ineffective quality system at Bausch and Lomb's Tampa manufacturing facility
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Japanese researchers report advances in liver disease treatment and cancer screening Two research teams in Japan have published findings that could open new avenues in metabolic disease treatment and non-invasive cancer screening
  4. FDA approves Telix’s first FET-PET imaging drug for glioma Telix’s Pixclara is the first FDA-approved FET-PET imaging agent for glioma, enabling US clinicians to distinguish recurrent or progressive brain tumours from treatment-related changes
  5. Exceptional excipients enabled with expertise Growing regulatory expectations, increasing pressure to secure resilient regional supply chains and the need for more efficient manufacturing are reshaping how medicines are developed and produced

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing The platform supports pharmaceutical companies in developing, evaluating and optimising formulations and processes for continuous manufacturing
DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

Read more
Manufacturing Enzene is a CIDMO partner supporting innovators and biosimilar developers from discovery to commercial supply with integrated, paradigm-changing biologics services and...
Enzene: Bringing the most advanced innovations to biologics manufacturing

Enzene: Bringing the most advanced innovations to biologics manufacturing

Read more
Research & Development The collaboration combines human-relevant in vitro immunology with in vivo pharmacology to support biotech drug discovery programmes, including endometriosis research
Oncodesign Services and Nexus BioQuest partner on preclinical drug development

Oncodesign Services and Nexus BioQuest partner on preclinical drug development

Read more
Manufacturing UK CDMO Upperton can now manufacture sterile investigational medicinal products at its new 7,000 sq ft facility in Nottingham, expanding its GMP clinical supply capabilities
Upperton gains MHRA licence for Annex 1-aligned sterile facility

Upperton gains MHRA licence for Annex 1-aligned sterile facility

Read more
Pharma 5.0 The next phase of AI adoption in pharma could be less about discovering new medicines and more about tackling the operational barriers that prevent AI projects from scaling,...
Beyond drug discovery: the untapped value of AI in pharma operations

Beyond drug discovery: the untapped value of AI in pharma operations

Read more
Manufacturing As demand for HPAPIs and highly potent drug products grows, the pharmaceutical industry faces increasing pressure to combine containment, product and operator protection,...
Beyond containment: integrated line design reduces risk and complexity

Beyond containment: integrated line design reduces risk and complexity

Read more
Manufacturing Free in-person workshop combines expert theory with hands-on laboratory sessions to build confidence in viscosity measurement
Anton Paar’s popular viscosity workshop returns to Luton this October

Anton Paar’s popular viscosity workshop returns to Luton this October

Read more
Manufacturing New spray drying, dry granulation and pharmaceutical development solutions showcased at CPHI Milan
Glatt presents integrated particle engineering solutions at CPHI Milan

Glatt presents integrated particle engineering solutions at CPHI Milan

Read more